Clinical Trial Update: Effect of Levosimendan on miRNAs Regulation in the Failing Hearts [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating the effect of levosimendan on microRNA regulation in patients with heart failure is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Tongji Hospital | Conditions: Heart Failure | Phase 4 | Status: UNKNOWN